isospaglumic acid has been researched along with Asymmetric Diabetic Proximal Motor Neuropathy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berent-Spillson, A; Golovoy, D; Robinson, AM; Rojas, C; Russell, JW; Slusher, B | 1 |
| Bzdega, T; Gehl, LM; Neale, JH; Olszewski, RT; Wroblewska, B | 1 |
1 review(s) available for isospaglumic acid and Asymmetric Diabetic Proximal Motor Neuropathy
| Article | Year |
|---|---|
The neurotransmitter N-acetylaspartylglutamate in models of pain, ALS, diabetic neuropathy, CNS injury and schizophrenia.
Topics: Amyotrophic Lateral Sclerosis; Animals; Brain Ischemia; Diabetic Neuropathies; Dipeptides; Glutamate Carboxypeptidase II; Humans; Pain; Protease Inhibitors; Schizophrenia | 2005 |
1 other study(ies) available for isospaglumic acid and Asymmetric Diabetic Proximal Motor Neuropathy
| Article | Year |
|---|---|
Protection against glucose-induced neuronal death by NAAG and GCP II inhibition is regulated by mGluR3.
Topics: Animals; Apoptosis; Cells, Cultured; Coculture Techniques; Diabetic Neuropathies; Dipeptides; Dose-Response Relationship, Drug; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Ganglia, Spinal; Glucose; Glutamate Carboxypeptidase II; Neurites; Neurons; Neuroprotective Agents; Organophosphorus Compounds; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Schwann Cells | 2004 |